We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Request Information

To request more information about this product, please complete the form below.

Gloved hands holding a vial with a depiction of DNA strands inside and on the background.
Credit: Evotec.
Request Information
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Featured Product
Advertisement

Oligonucleotide Solutions from Target ID and Validation to IND

Oligonucleotide Solutions from Target ID and Validation to IND
Credit: Evotec.

We offer complete integrated or stand alone oligonucleotide drug discovery solutions to take you from target to the clinic including GLP safety studies. Our extensive expertise in developing oligonucleotide drugs coupled with our comprehensive disease biology understanding ensures you get to your next decision point fast.


Product Specifications
Your Partner for Success  
Disease Biology Expertise  
End-to-End Oligonucleotide Solutions  
Oligonucleotide Design  
Expert Chemistry  
PK/PD & Flexible Bio Analytics  
Efficacy, target engagement & Early Safety Studies  
Integrated Development to Support First-in-Human  
About Evotec
Evotec are a R&D biotech that offers accelerating, high value pipeline co-creation partnerships and comprehensive CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond. Our expertise spans across therapeutic/disease areas and most modalities, especially small molecules and biotherapeutics. We take pride in acting as "drug hunters" in deep collaboration with our partners to advance science. At the core of our operations are our industrialized, AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies. These platforms are instrumental in enhancing disease understanding and ensuring human relevance in our research. By integrating AI and continuous manufacturing technology, we facilitate better access to high-quality biotherapeutics, revolutionizing the way treatments are developed and produced.
Interested in seeing more content from Evotec?
Discover all their latest news, webinars, products and more by clicking the link below.